IMCD acquires Jucker Pharma’s agency business, Sweden
ROTTERDAM, The Netherlands (8 May, 2014) – IMCD Group B.V. is delighted to announce that it
has signed an agreement to acquire the agency business of Stockholm-based Jucker Pharma, a
well established distributor of raw materials to the Nordic pharmaceutical industry. The acquisition
will bring a number of new principals and customers to the Group within the API industry. Jucker
Pharma will continue to operate in a limited capacity in fields outside of IMCD’s core distribution
business. The transaction is expected to be completed on 31 May 2014.
Established in 1948, Jucker Pharma is primarily active in the Nordics and Baltics employing four members of staff including owner and Managing Director Christian Jucker. As a major player within the Nordic pharmaceutical raw materials market, Jucker Pharma has extensive industry experience and long-term supplier partnerships.
Didrik von Porat, Managing Director IMCD Sweden, comments: “Corresponding with IMCD Pharma’s strategy to further expand into APIs in Europe, the acquisition of Jucker Pharma’s agency business will ensure a greater product offering to IMCD’s customers. Jucker Pharma holds a very strong position within the API market and is therefore a great complement to IMCD’s pharma business, presenting a platform for future growth.”
Christian Jucker adds: “Having been in discussions with IMCD for some time, we are infinitely confident in the success of this acquisition. IMCD is viewed as the most natural fit due to its international reputation and its comprehensive coverage of the additive and excipient markets bringing a more balanced portfolio.”